Surgery for endometriosis may involve several organs (vagina, uterus, ovary...
Surgery for endometriosis may involve several organs (vagina, uterus, ovary) and sometimes may involve opening of intestinal tract. Evidence...
15 Mar, 2019
Maternal exposure to fluconazole during pregnancy was associated with an increased risk of spontaneous abortion and cardiac septal closure anomalies...
28 Feb, 2019
Assisted reproductive technologies (ART) are associated with greater risk of adverse pregnancy outcomes and long-term consequences for both the...
27 Feb, 2019
The current study suggested that parental subfecundity and medically assisted reproduction (MAR) did not significantly impact the child’s long-term...
21 Feb, 2019
This document gives the revised recommended dosages of misoprostol when used alone, for a variety of gynaecologic and obstetric indications. The...
This article discusses the clinical outcomes using modified dosage regimes of clomiphene citrate for ovulation induction.
Up to 3% of pregnant women suffer from pregnancy-associated liver diseases, which are the most frequent cause of liver dysfunction in pregnancy. Due...
Chronic hepatitis B virus (HBV) infection in pregnancy is an important global health problem. Over 50% of the estimated 240–350 million chronic...
Dienogest is an oral progestin with unique pharmacological properties, and is indicated at a dosage of 2 mg/day for the management of pelvic pain...
Endometriosis is the presence of endometrial tissue outside the uterine cavity and has a burden of around 176 million women globally. These slides...
Hepatitis C virus (HCV) infection during pregnancy is an emerging problem. While not negatively affecting acute hepatitis, it may exacerbate chronic...
Breastfeeding is meant to be a comfortable and pleasant experience. It is also an integral part of the reproductive process with important...
Treatment with dienogest 2 mg daily over a period of 60 months was significantly effective in reducing endometriosis-associated pelvic pain and...
Dienogest 2 mg daily was the lowest effective dose for the treatment of endometriosis with a slightly superior tolerability profile than 4 mg dose....
The study concluded that the efficacy of dienogest 2 mg daily for 12 weeks was superior to placebo in reducing the endometriosis-associated pelvic...
This non-inferiority trial demonstrated comparable efficacy of dienogest 2 mg daily to leuprolide acetate depot in reducing the endometriosis-...